Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-02-23 @ 9:23 PM
Study NCT ID:
NCT03725761
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-13
First Post:
2018-10-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-09
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-15
First Submit QC Date:
None
Study First Post Date:
2018-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-02
Results First Submit QC Date:
None
Results First Post Date:
2025-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-05
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL